SKP2 and melanoma: Another study by Sumimoto et al. revealed that the combined suppression of BRAFV599E and Skp2 inhibited cell growth and attenuated the invasive potential of melanoma cell lines in vitro prompting speculation regarding the possibility of combination therapy targeting BRAF and Skp2 [40].